{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:28:18Z","timestamp":1786994898235,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.neuropharm.2020.108287","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T11:31:27Z","timestamp":1598441487000},"page":"108287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Differential glutamatergic and GABAergic contributions to the tetrad effects of \u03949-tetrahydrocannabinol revealed by cell-type-specific reconstitution of the CB1 receptor"],"prefix":"10.1016","volume":"179","author":[{"given":"Vanessa","family":"De Giacomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Ruehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floortje","family":"Remmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108287_bib1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1916","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors","volume":"10","author":"Agarwal","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0306-4522(00)00389-4","article-title":"Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons","volume":"100","author":"Ahluwalia","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108287_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nn.2494","article-title":"Bimodal control of stimulated food intake by the endocannabinoid system","volume":"13","author":"Bellocchio","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fncom.2013.00163","article-title":"Motor thalamus integration of cortical, cerebellar and basal ganglia information: implications for normal and parkinsonian conditions","volume":"7","author":"Bosch-Bouju","year":"2013","journal-title":"Front. Comput. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mds.25096","article-title":"New synaptic and molecular targets for neuroprotection in Parkinson's disease","volume":"28","author":"Calabresi","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2020.108287_bib6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/nn.3743","article-title":"Direct and indirect pathways of basal ganglia: a critical reappraisal","volume":"17","author":"Calabresi","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-3565(25)12911-X","article-title":"In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity","volume":"277","author":"Compton","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108287_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3565(25)11216-0","article-title":"Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents","volume":"260","author":"Compton","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108287_bib9","doi-asserted-by":"crossref","first-page":"13693","DOI":"10.1073\/pnas.1514962112","article-title":"Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons","volume":"112","author":"de Salas-Quiroga","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2020.108287_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0304-3959(03)00068-X","article-title":"Topical cannabinoid antinociception: synergy with spinal sites","volume":"105","author":"Dogrul","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108287_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pnpbp.2012.01.007","article-title":"Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception","volume":"38","author":"Dogrul","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108287_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1006\/mcne.2000.0844","article-title":"Cannabinoid CB1 receptor expression in rat spinal cord","volume":"15","author":"Farquhar-Smith","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1476-5381.1982.tb08802.x","article-title":"Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol","volume":"75","author":"Fitton","year":"1982","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00474-7","article-title":"The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain","volume":"92","author":"Fox","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108287_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0705466","article-title":"Emerging roles for endocannabinoids in long-term synaptic plasticity","volume":"140","author":"Gerdeman","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/dvg.20256","article-title":"Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice","volume":"44","author":"Goebbels","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.neuropharm.2020.108287_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnins.2012.00053","article-title":"Development of the corticothalamic projections","volume":"6","author":"Grant","year":"2012","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib18","doi-asserted-by":"crossref","first-page":"R509","DOI":"10.1016\/S0960-9822(00)00593-5","article-title":"The basal ganglia","volume":"10","author":"Graybiel","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0166-2236(97)01157-0","article-title":"Paying attention to the thalamic reticular nucleus","volume":"21","author":"Guillery","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cne.24066","article-title":"Anatomical characterization of the cannabinoid CB1 receptor in cell-type-specific mutant mouse rescue models","volume":"525","author":"Guti\u00e9rrez-Rodr\u00edguez","year":"2017","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108287_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108287_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108287_bib24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1523\/JNEUROSCI.1945-17.2017","article-title":"Acetaminophen relieves inflammatory pain through CB1 cannabinoid receptors in the rostral ventromedial medulla","volume":"38","author":"Klinger-Gratz","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nature09159","article-title":"Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108287_bib26","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1073\/pnas.93.12.5860","article-title":"Efficient in vivo manipulation of mouse genomic sequences at the zygote stage","volume":"93","author":"Lakso","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2020.108287_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108287_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(91)90017-P","article-title":"Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism","volume":"559","author":"Lichtman","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108287_bib29","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0022-3565(25)13256-4","article-title":"Pharmacology and stereoselectivity of structurally novel cannabinoids in mice","volume":"247","author":"Little","year":"1988","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108287_bib30","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.neuropharm.2012.01.025","article-title":"Role of the anterior thalamic nucleus in the motor hyperactivity induced by systemic MK-801 administration in rats","volume":"62","author":"L\u00f3pez Hill","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108287_bib31","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib32","first-page":"108","article-title":"Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids","volume":"79","author":"Martin","year":"1987","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neuropharm.2020.108287_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108287_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108287_bib35","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1523\/JNEUROSCI.22-18-08117.2002","article-title":"Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas","volume":"22","author":"McFarland","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuroscience.2016.08.047","article-title":"CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy","volume":"337","author":"Medeiros","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108287_bib38","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pbio.0050269","article-title":"Genetic dissection of behavioural and autonomic effects of \u03949-tetrahydrocannabinol in mice","volume":"5","author":"Monory","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108287_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0024-3205(99)00286-6","article-title":"Presence and functional regulation of cannabinoid receptors in immune cells","volume":"65","author":"Parolaro","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib40","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1171870","article-title":"Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization","volume":"325","author":"Pern\u00eda-Andrade","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108287_bib41","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1124\/jpet.301.3.963","article-title":"CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia","volume":"301","author":"Rawls","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108287_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1124\/jpet.102.037473","article-title":"N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia","volume":"303","author":"Rawls","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108287_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pbb.2004.02.006","article-title":"GABAA receptors modulate cannabinoid-evoked hypothermia","volume":"78","author":"Rawls","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108287_bib44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bjp.0707440","article-title":"Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate","volume":"152","author":"Rea","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib45","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1007\/s00429-017-1411-5","article-title":"Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons","volume":"222","author":"Remmers","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2020.108287_bib46","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108287_bib47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2020.108287_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1213\/ANE.0b013e3182707859","article-title":"CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system","volume":"116","author":"Romero","year":"2013","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2020.108287_bib49","doi-asserted-by":"crossref","first-page":"10264","DOI":"10.1523\/JNEUROSCI.4171-12.2013","article-title":"Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions","volume":"33","author":"Ruehle","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(00)00044-3","article-title":"Activational role of cannabinoids on movement","volume":"391","author":"Sa\u00f1udo-Pe\u00f1a","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib51","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1523\/JNEUROSCI.20-10-03714.2000","article-title":"Neuronal basic helix-loop-helix proteins (NEX and BETA2\/Neuro D) regulate terminal granule cell differentiation in the hippocampus","volume":"20","author":"Schwab","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108287_bib52","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/jnc.12137","article-title":"Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus","volume":"124","author":"Steindel","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108287_bib53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108287_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2003.08.101","article-title":"The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders","volume":"480","author":"van der Stelt","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib55","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/bph.14958","article-title":"Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: opposite roles of CB1\/CB2 versus GPR55 receptors","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(03)01856-9","article-title":"Cannabinoid pharmacological properties common to other centrally acting drugs","volume":"471","author":"Wiley","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108287_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2017.06.015","article-title":"The cannabinoid system and pain","volume":"124","author":"Woodhams","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108287_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2010.07.019","article-title":"A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain","volume":"151","author":"Yu","year":"2010","journal-title":"PAIN\u00ae"},{"key":"10.1016\/j.neuropharm.2020.108287_bib60","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","article-title":"Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice","volume":"96","author":"Zimmer","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:06:37Z","timestamp":1758438397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820303555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":60,"alternative-id":["S0028390820303555"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108287","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential glutamatergic and GABAergic contributions to the tetrad effects of \u03949-tetrahydrocannabinol revealed by cell-type-specific reconstitution of the CB1 receptor","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108287"}}